2012 Annual Base Salary Schedule for Executive Officers of the Company
This document outlines the 2012 annual base salaries for the company's executive officers, listing each officer's name, title, prior base salary, and new base salary for 2012. The agreement applies to key executives including the President and CEO, Senior Vice Presidents, Chief Scientific Officer, and Chief Financial Officer. Some salary increases are prorated for those hired in 2011. The document serves as a record of compensation adjustments for the company's top management for the year 2012.
Exhibit 10.4
2012 Annual Base Salaries
| Executive Officer | Prior Base Salary | 2012 Base Salary | ||||||
| Douglas C. Bryant President and Chief Executive Officer | $ | 482,040 | $ | 496,501 | ||||
| Robert J. Bujarski Senior Vice President, Business Development and General Counsel | $ | 311,472 | $ | 320,816 | ||||
| Scot M. McLeod Senior Vice President, Operations | $ | 276,841 | $ | 285,146 | ||||
| Mark Smits Senior Vice President, Commercial Operations, North America | $ | 285,000 | $ | 290,700 | * | |||
| Timothy T. Stenzel Chief Scientific Officer | $ | 299,421 | $ | 308,404 | ||||
| Randall Steward Chief Financial Officer | $ | 300,000 | $ | 303,000 | * | |||
| John D. Tamerius Senior Vice President, Clinical and Regulatory Affairs | $ | 281,726 | $ | 290,178 | ||||
| * | Prorated salary increase for those hired by the Company in calendar year 2011. |
